Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.19.2
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Equity [Abstract]  
Number of warrants outstanding, beginning | shares 644,083
Number of warrants issued | shares 718,750
Number of warrants cancelled | shares 0
Number of warrants exercised | shares 0
Number of warrants forfeited | shares 0
Number of warrants outstanding, ending | shares 1,362,833
Number of warrants exercisable | shares 1,362,833
Weighted average exercise price outstanding, beginning $ 1.77
Weighted average exercise price granted .20
Weighted average exercise price cancelled .00
Weighted average exercise price exercised .00
Weighted average exercise price forfeited .00
Weighted average exercise price outstanding, ending .94
Weighted average exercise price exercisable .94
Weighted average fair value of warrants granted during the period $ 1.55
Weighted average remaining contractual life outstanding, beginning 1 year 4 months 17 days
Weighted average remaining contractual life granted 5 years
Weighted average remaining contractual life outstanding, ending 3 years 1 month 28 days
Weighted average remaining contractual life exercisable 3 years 1 month 28 days